Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia

NCT02390375 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

348

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: DW-0929
DRUG: DW-0929
DRUG: DW-0929
DRUG: Rosuvastatin
DRUG: Rosuvastatin
DRUG: Rosuvastatin

Sponsor

Daewon Pharmaceutical Co., Ltd.